Erick H Turner

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. ncbi A taxpayer-funded clinical trials registry and results database
    Erick H Turner
    PLoS Med 1:e60. 2004
  2. ncbi Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database
    Erick H Turner
    Department of Psychiatry, Oregon Health and Science University, Portland, Oregon, USA
    PLoS Med 9:e1001189. 2012
  3. ncbi Selective publication of antidepressant trials and its influence on apparent efficacy
    Erick H Turner
    Department of Psychiatry, Oregon Health and Science University, Portland, OR, USA
    N Engl J Med 358:252-60. 2008
  4. ncbi Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center
    Steven K Dobscha
    Portland Veterans Affairs Medical Center, Oregon 97207, USA
    Psychiatr Serv 54:195-200. 2003
  5. ncbi 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin
    Erick H Turner
    Mental Health Division, Mood Disorders Research Center, Portland VA Medical Center, 3710 SW US Veterans Hospital Rd, Portland, OR 97239, USA
    Med Hypotheses 65:138-44. 2005
  6. ncbi Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan
    Erick H Turner
    Mood Disorders Center, Portland VA Medical Center, Portland, OR 97239, USA
    Pharmacol Ther 109:325-38. 2006
  7. ncbi Closing a loophole in the FDA Amendments Act
    Erick H Turner
    Science 322:44-6. 2008
  8. ncbi Efficacy of antidepressants
    Erick H Turner
    BMJ 336:516-7. 2008
  9. ncbi Posting FDA new drug application reviews
    Erick H Turner
    JAMA 298:863-4. 2007
  10. ncbi Double-blind, placebo-controlled study of single-dose metergoline in depressed patients with seasonal affective disorder
    Erick H Turner
    Section on Biological Rhythms, Intramural Research Program, National Institute of Mental Health, Bethesda, Maryland, USA
    J Clin Psychopharmacol 22:216-20. 2002

Detail Information

Publications10

  1. ncbi A taxpayer-funded clinical trials registry and results database
    Erick H Turner
    PLoS Med 1:e60. 2004
  2. ncbi Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database
    Erick H Turner
    Department of Psychiatry, Oregon Health and Science University, Portland, Oregon, USA
    PLoS Med 9:e1001189. 2012
    ..Thus one may determine whether publication bias is present and quantify the extent to which it inflates apparent drug efficacy...
  3. ncbi Selective publication of antidepressant trials and its influence on apparent efficacy
    Erick H Turner
    Department of Psychiatry, Oregon Health and Science University, Portland, OR, USA
    N Engl J Med 358:252-60. 2008
    ..Selective publication of clinical trials--and the outcomes within those trials--can lead to unrealistic estimates of drug effectiveness and alter the apparent risk-benefit ratio...
  4. ncbi Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center
    Steven K Dobscha
    Portland Veterans Affairs Medical Center, Oregon 97207, USA
    Psychiatr Serv 54:195-200. 2003
    ..The authors examined the efficacy of a multifaceted intervention designed to contain the cost of prescribing selective serotonin reuptake inhibitors (SSRIs) to inpatients and outpatients served by a Veterans Affairs (VA) medical center...
  5. ncbi 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin
    Erick H Turner
    Mental Health Division, Mood Disorders Research Center, Portland VA Medical Center, 3710 SW US Veterans Hospital Rd, Portland, OR 97239, USA
    Med Hypotheses 65:138-44. 2005
    ..Several double-blind studies have shown 5-HTP to be effective in the treatment of nondrug-induced depression. We hypothesize that patients who become depressed on IFN will respond to the synergistic combination of SSRIs plus 5-HTP...
  6. ncbi Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan
    Erick H Turner
    Mood Disorders Center, Portland VA Medical Center, Portland, OR 97239, USA
    Pharmacol Ther 109:325-38. 2006
    ..Safety issues with 5-HTP are also reviewed, with emphasis on eosinophilia myalgia syndrome (EMS) and serotonin syndrome...
  7. ncbi Closing a loophole in the FDA Amendments Act
    Erick H Turner
    Science 322:44-6. 2008
  8. ncbi Efficacy of antidepressants
    Erick H Turner
    BMJ 336:516-7. 2008
  9. ncbi Posting FDA new drug application reviews
    Erick H Turner
    JAMA 298:863-4. 2007
  10. ncbi Double-blind, placebo-controlled study of single-dose metergoline in depressed patients with seasonal affective disorder
    Erick H Turner
    Section on Biological Rhythms, Intramural Research Program, National Institute of Mental Health, Bethesda, Maryland, USA
    J Clin Psychopharmacol 22:216-20. 2002
    ..These data suggest that single doses of metergoline may have antidepressant effects that last several days. Possible mechanisms include 5-hydroxytryptamine(2) receptor downregulation and dopamine agonism...